K. Harzer et B. Kustermann-kuhn, Quantified increases of cholesterol, total lipid and globotriaosylceramidein filipin-positive Niemann-Pick type C fibroblasts, CLIN CHIM A, 305(1-2), 2001, pp. 65-73
Background: Niemann-Pick disease type C (NPC) is a neurovisceral lysosomal
lipidosis caused in most cases by mutations in the NPC1 gene that codes for
the cholesterol regulating NPC1 protein. Methods: Cultured skin fibroblast
s from 11 NPC patients aged 0.25 to 34 years at diagnosis with different se
verity of neurologic and visceral involvement, diagnosed by the cytochemica
l filipin test for lysosomally stored cholesterol, were analyzed for lipid
composition. Cholesterol and other lipids were separated on thin-layer chro
matography from fibroblast total lipid extracts, quantified by densitometry
and compared with the total cell lipid mass. Results: Cholesterol concentr
ation in the patient cells was 1.5 to 5-fold higher than normal and total l
ipids up to 2.4-fold normal. Cholesterol and total lipids were particularly
high in cells from NPC patients aged less than about 6 years, and for-the
whole patient series the abundance of fibroblast cholesterol was correlated
with the tentatively assessed clinical disease severity. The findings in N
PC suggested that NPC1 protein has a role not only in the balance of choles
terol but also the distribution of the total cell lipid mass. Another incre
ase found in the NPC cells was that of a minor lipid fraction, globotriaosy
lceramide (Gb3, known as a cell signalling glycolipid). Gb3, in the average
of its very variable individual concentrations, was about 2.5-fold higher
in the NPC cell group as compared to normal or pathologic control group, bu
t there was no correlation of Gb3 with the other lipid concentrations studi
ed. Conclusions: For NPC diagnosis, the fibroblast cholesterol and total li
pid quantification can be used as an alternative to the usual filipin test
for lysosomal cholesterol, but both test methods are prone to equivocal res
ults in cells from a small fraction of atypical NPC patients, where chemica
l testing in organ biopsies or mutational analysis of the NPC1 gene should
be tried. (C) 2001 Elsevier Science B.V. All rights reserved.